Add Yahoo as a preferred source to see more of our stories on Google. Inspire Sleep Apnea Innovation Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or ...

The first-ever sleep apnea pill cut breathing episodes by over 50% in Phase 3 trials. Here's the data and when to expect FDA ...

Athens-Limestone Hospital introduces the FDA-approved Genio system to North Alabama, offering innovative nerve stimulation ...

AD109 works by targeting neuromuscular dysfunction of upper airway muscles during sleep, representing a potential new ...

A surprising gut-heart connection may help explain why sleep apnea increases the risk of cardiovascular disease. In mice, ...

Sleep apnea used to be managed by puncturing the neck, but treatments for the common condition in the near-future promise to be far less intrusive. Reading time 6 minutes Snoring is routinely a ...

New research shows GLP-1 drugs like Ozempic may reduce sleep apnea severity — here's what the latest science says ...

The new treatment could hit the market as early as 2027.

ALSO BE AN INDICATION OF SLEEP APNEA CONCERNS. OTHER REPORTS LOOKS AT THE SLEEP TREATMENT THAT CAN GIVE YOU AND YOURS SOME LONG AWAITED, UNINTERRUPTED SLEEP. SNORING IS NOT JUST ANNOYING, IT CAN KEEP ...

Promising results in sleep apnea pill could eliminate patient need for uncomfortable CPAP machine - Leaving obstructive sleep ...

Researchers recently tested a medicine called AD109 in a large phase 3 clinical trial and found encouraging results. The treatment is a once-nightly oral pill designed specifically for obstructive ...

A new study to be presented at the SLEEP 2026 annual meeting found that women with moderate-to-severe obstructive sleep apnea ...